Allison McGeer
Impact in
- Infectious Diseases top 0.01%
- Antimicrobial Resistance in Staphylococcus
- Applied Microbiology and Biotechnology top 0.05%
Papers in
-
- Antimicrobial Resistance in Staphylococcus 118
- SARS-CoV-2 and COVID-19 Research 43
- Co-authors
- Donald E. LowAndrew E. SimorKaren GreenBarbara WilleyMark LoebBenjamin SchwartzAnna Norrby‐TeglundMalak Kotb
- Journals
- Infection Control and Hospital Epidemiology (67 papers)Clinical Infectious Diseases (41 papers)Antimicrobial Agents and Chemotherapy (25 papers)Journal of Clinical Microbiology (21 papers)Emerging infectious diseases (21 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Allison McGeer
561 papers receiving 29.2k citations
Hit Papers
Peers
Comparison fields: 5 of 206
- Infectious Diseases 13.3k
- Applied Microbiology and Biotechnology 1.3k
- Clinical Biochemistry 3.1k
- Molecular Medicine 2.2k
- Epidemiology 13.0k
Countries citing papers authored by Allison McGeer
This map shows the geographic impact of Allison McGeer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison McGeer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison McGeer more than expected).
Fields of papers citing papers by Allison McGeer
This network shows the impact of papers produced by Allison McGeer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison McGeer. The network helps show where Allison McGeer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Allison McGeer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 175 | |
| 9 | 2020 | 37 | |
| 10 | 2020 | 8 | |
| 11 | 2019 | 24 | |
| 12 | Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection Hit paper breakdown → | 2018 | 773 |
| 13 | 2018 | 19 | |
| 14 | 2016 | 25 | |
| 15 | 2015 | 1 | |
| 16 | 2014 | 197 | |
| 17 | 2004 | 249 | |
| 18 | 1995 | 8 | |
| 19 | 1995 | 9 | |
| 20 | 1993 | 3 |
About Allison McGeer
Allison McGeer is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Clinical Biochemistry, Epidemiology and Molecular Medicine, having authored 581 papers that have together received 30.4k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (118 papers), Streptococcal Infections and Treatments (108 papers), Influenza Virus Research Studies (105 papers), Respiratory viral infections research (103 papers), Pneumonia and Respiratory Infections (99 papers), Bacterial Identification and Susceptibility Testing (72 papers), SARS-CoV-2 and COVID-19 Research (43 papers) and Neonatal and Maternal Infections (41 papers). The work is most often cited by research in Infectious Diseases (13.3k citations), Applied Microbiology and Biotechnology (1.3k citations), Clinical Biochemistry (3.1k citations), Molecular Medicine (2.2k citations) and Epidemiology (13.0k citations). Allison McGeer has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Donald E. Low, Andrew E. Simor, Donald E. Low, Karen Green, Barbara Willey, Mark Loeb, Benjamin Schwartz, Anna Norrby‐Teglund, Malak Kotb and Joyce C. de Azavedo. Their work appears in journals such as Infection Control and Hospital Epidemiology, Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.